Literature DB >> 15104298

Caveolin and thrombospondin expression during hepatocellular carcinogenesis.

Lisa M Yerian1, Robert A Anders, Maria Tretiakova, John Hart.   

Abstract

Macroregenerative and dysplastic nodules (MDNs) are hepatocellular carcinoma (HCC) precursor lesions and exhibit distinct vascular profiles relative to adjacent cirrhotic liver. Recent microarray analysis of MDN identified aberrant expression of caveolin-1 and thrombospondin-1, genes suspected to play a role in tumorigenesis at other sites. We used immunohistochemistry to localize caveolin and thrombospondin expression in 14 MDNs from livers with hepatitis C cirrhosis and in tissue arrays that included samples of MDNs, HCC, and nonneoplastic liver. Hepatocytes were uniformly negative for caveolin. Sinusoidal endothelial cells exhibited increased caveolin expression in MDNs relative to adjacent cirrhotic liver in most (28 of 36, 78%) MDNs evaluated. However, few HCCs showed increased caveolin expression as compared with nonneoplastic liver (5 of 19, 26%). Unpaired arteries showed strong positive endothelial cell staining. Thrombospondin staining was weak or negative in hepatocytes in nearly all (77 of 92, 84%) MDNs and in 46 of 49 HCCs evaluated (94%). Sinusoidal endothelial cells were negative for thrombos pondin, but hepatic arteries and MDNs showed positive mural staining; portal veins were positive both in vessel walls and in endothelial cells. The altered expression profiles of these genes identified in microarray analysis are not likely related directly to malignant transformation of hepatocytes but rather to an alteration in the vascular supply to these lesions. The results illustrate the critical role of histologic techniques in interpretation of microarray data.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15104298     DOI: 10.1097/00000478-200403000-00008

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  11 in total

1.  O Labeling for a Quantitative Proteomic Analysis of Glycoproteins in Hepatocellular Carcinoma.

Authors:  Raghothama Chaerkady; Paul J Thuluvath; Min-Sik Kim; Anuradha Nalli; Perumal Vivekanandan; Jessica Simmers; Michael Torbenson; Akhilesh Pandey
Journal:  Clin Proteomics       Date:  2008-07-18       Impact factor: 3.988

2.  Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer.

Authors:  Yu Tang; Xiangtian Zeng; Fei He; Yonghui Liao; Niansong Qian; Masakazu Toi
Journal:  Med Oncol       Date:  2011-03-17       Impact factor: 3.064

3.  Expression and significance of caveolin-1 in hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Hao Cheng; Yiming Pan; Yongzhong Yao; Zhanghua Zhu; Jun Chen; Xitai Sun; Yudong Qiu; Yitao Ding
Journal:  Exp Ther Med       Date:  2017-08-25       Impact factor: 2.447

4.  Impairment of transforming growth factor beta signaling in caveolin-1-deficient hepatocytes: role in liver regeneration.

Authors:  Rafael Mayoral; Ángela M Valverde; Cristina Llorente Izquierdo; Águeda González-Rodríguez; Lisardo Boscá; Paloma Martín-Sanz
Journal:  J Biol Chem       Date:  2009-12-05       Impact factor: 5.157

Review 5.  Role of thrombospondin 1 in liver diseases.

Authors:  Yanzhang Li; Courtney P Turpin; Shuxia Wang
Journal:  Hepatol Res       Date:  2016-08-30       Impact factor: 4.288

6.  Caveolin-1 overexpression in benign and malignant salivary gland tumors.

Authors:  Zohreh Jaafari-Ashkavandi; Mohammad Javad Ashraf; Ali Dehghani Nazhvani; Zahra Azizi
Journal:  Tumour Biol       Date:  2015-09-01

7.  Thrombospondin-1 expression correlates with angiogenesis in experimental cirrhosis.

Authors:  Gulsum-Ozlem Elpek; Guzide-Ayse Gokhan; Sevgi Bozova
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

8.  Overexpression of caveolin-1 in hepatocellular carcinoma with metastasis and worse prognosis: correlation with vascular endothelial growth factor, microvessel density and unpaired artery.

Authors:  Zhi-Bo Zhang; Lei Cai; Shu-Guo Zheng; Yan Xiong; Jia-Hong Dong
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

9.  A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma.

Authors:  Raghothama Chaerkady; H C Harsha; Anuradha Nalli; Marjan Gucek; Perumal Vivekanandan; Javed Akhtar; Robert N Cole; Jessica Simmers; Richard D Schulick; Sujay Singh; Michael Torbenson; Akhilesh Pandey; Paul J Thuluvath
Journal:  J Proteome Res       Date:  2008-08-21       Impact factor: 4.466

10.  A novel antihepatitis drug, bicyclol, prevents liver carcinogenesis in diethylnitrosamine-initiated and phenobarbital-promoted mice tumor model.

Authors:  Hua Sun; Linghong Yu; Huailing Wei; Gengtao Liu
Journal:  J Biomed Biotechnol       Date:  2012-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.